Moungondo, Fabian
Van Rompaey, Hannah
Moussa, Mohamad K.
Schuind, Frédéric
Article History
Received: 12 September 2023
Accepted: 22 November 2023
First Online: 10 April 2024
Declarations
:
: Fabian Moungondo, MD, PhD received royalties from Spirecut. Frédéric Schuind, MD, PhD holds shares in Spirecut.
: This study was approved by the Central Ethics Committee of the Belgian Federal Agency for Medicines and Health Products (Aug. 18, 2022) and recorded in ClinicalTrials.gov with as identifier NCT05435950.